Bjrn Berg - Ngenic AB CEO MD
| NGENIC Stock | 0.12 0.01 9.09% |
Insider
Bjrn Berg is CEO MD of Ngenic AB
| Age | 55 |
| Phone | 46 1 84 72 18 18 |
| Web | https://ngenic.se |
Ngenic AB Management Efficiency
The company has return on total asset (ROA) of (0.222) % which means that it has lost $0.222 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5402) %, meaning that it generated substantial loss on money invested by shareholders. Ngenic AB's management efficiency ratios could be used to measure how well Ngenic AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Markus Waldenstrom | Greater Than AB | 34 | |
| Lars Jatko | Greater Than AB | 47 | |
| Eva Voors | Greater Than AB | 57 | |
| Jim Noble | Greater Than AB | N/A | |
| LLB LLB | Concejo AB | 58 | |
| Pr Olivecrona | Lipigon Pharmaceuticals AB | 71 | |
| Liselott Johansson | Greater Than AB | 48 | |
| AnnaTove Branemark | Integrum AB Series | 56 | |
| Stefan Nilsson | Lipigon Pharmaceuticals AB | 44 | |
| Sten Forseke | Greater Than AB | 64 | |
| Jimmy Palmqvist | Greater Than AB | 54 | |
| Lars hman | Lipigon Pharmaceuticals AB | 66 | |
| James Sheridan | Integrum AB Series | 58 | |
| Thorleif Jener | Concejo AB | 61 | |
| Mathias Osterdahl | Concejo AB | 53 | |
| Johanna Forseke | Greater Than AB | 33 | |
| Helena Norrthon | Greater Than AB | 52 | |
| Andrew Bennett | Greater Than AB | N/A | |
| Rickard Branemark | Integrum AB Series | 63 | |
| Jonas Hellberg | Diadrom Holding AB | N/A | |
| Michael Owens | Lipigon Pharmaceuticals AB | 67 | |
Management Performance
| Return On Equity | -0.54 | |||
| Return On Asset | -0.22 |
Ngenic AB Leadership Team
Elected by the shareholders, the Ngenic AB's board of directors comprises two types of representatives: Ngenic AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ngenic. The board's role is to monitor Ngenic AB's management team and ensure that shareholders' interests are well served. Ngenic AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ngenic AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fredrik Fernlund, CSO Founder | ||
| Olle Lindbom, Chief Officer | ||
| Anders Nygren, Chief Officer | ||
| Victoria Lenander, CCO | ||
| Daniel Mazmanian, Chief Officer | ||
| Bjrn Berg, CEO MD |
Ngenic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ngenic AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.54 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.70) % | |||
| Operating Margin | (0.68) % | |||
| Current Valuation | 207.59 M | |||
| Shares Outstanding | 6.71 M | |||
| Price To Book | 4.43 X | |||
| Price To Sales | 6.21 X | |||
| Revenue | 18.84 M | |||
| Gross Profit | 18.58 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Ngenic Stock
Ngenic AB financial ratios help investors to determine whether Ngenic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ngenic with respect to the benefits of owning Ngenic AB security.